Authored By: Sarah
11 Jul 2024

 Toxicology Testing Market Size to grow by USD 32.58 billion between 2024-2028

According to a research report “ Toxicology Testing Market” by End-user (Pharmaceutical industry, Food industry, Chemicals and others) Technology (Cell culture technology, High throughput technology, Molecular imaging, OMICS technology) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 32.58 billion, at a CAGR of  15.61% during the forecast period. In the food industry, regulatory compliance is of utmost importance to maintain the safety and integrity of consumer products. Regulatory bodies such as the Food and Drug Administration (FDA) in the US and the European Food Safety Authority (EFSA) in Europe play a crucial role in safeguarding public health by implementing stringent food safety regulations and enforcing compliance. These regulations aim to prevent foodborne illnesses, contamination, and outbreaks, which can pose significant health risks. Toxicity testing is an integral part of ensuring food safety. By conducting comprehensive testing for contaminants, toxins, and hazardous substances, food manufacturers and regulatory agencies can mitigate potential health risks and protect consumers from adverse health effects resulting from the consumption of contaminated or adulterated food products.

Browse market data tables, figures, and in-depth TOC on “Toxicology Testing Market” by End-user (Pharmaceutical industry, Food industry, Chemicals and others) Technology (Cell culture technology, High throughput technology, Molecular imaging, OMICS technology) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By End-user, the Pharmaceutical industry segment is projected to dominate the market size in 2024

In the realm of toxicology testing, cell culture technology plays a pivotal role in evaluating the biological activity of chemicals through the assessment of cellular functions. This process involves the use of various cell types, such as fibroblasts, HeLa, and hepatoma cells, to estimate the impact of test substances on cellular health. Endpoints, including vital staining, cytosolic enzyme release, cell proliferation, and cloning effectiveness, are employed to quantify toxicity. Furthermore, specialized cells, like primary hepatocytes, mixed myocardial cells, and myocytes, macrophages, are utilized to assess the influence of harmful substances on specific organs. By examining alterations in membrane integrity, metabolism, and organ-specific cell functions, toxicologists can gain valuable insights into the potential hazards posed by various compounds.

By Technology, Cell culture technology  segment is expected to hold the largest market size for the year 2024

In the pharmaceutical industry, toxicology testing plays a crucial role in the commercialization of new drugs and biologics. Compliance with regulatory guidelines, such as those set forth by the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other international regulatory bodies, necessitates extensive toxicology testing. This process evaluates the safety and biological effects of drugs and chemical agents on living organisms, ensuring that they are safe for human use before advancing to clinical trials. Pharmaceutical companies invest significantly in preclinical studies to meet regulatory requirements and ultimately bring innovative healthcare solutions to market.

North America is forecasted to hold the largest market size by region in 2024

The Toxicology Testing Market encompasses the production, sale, and application of diagnostic tools and services used to identify harmful substances in various matrices, including biological samples and environmental specimens. Market growth is driven by increasing regulatory requirements, rising awareness of workplace safety, and advancements in testing technologies. Companies in this sector offer solutions for various applications, including drug testing, food and water testing, and environmental monitoring. The market is expected to grow significantly due to these factors and the continuous development of innovative testing methods.

The Toxicology Testing Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Danaher Corp.
  • BioIVT LLC
  • Bio Rad Laboratories Inc.
  • Catalent Inc.
  • CompuDrug Ltd.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Merck KGaA
  • PerkinElmer Inc
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • SGS SA
  • Aragen Life Sciences Pvt. Ltd.
  • BICO Group AB
  • Ingenza Ltd
  • Randox Laboratories Ltd.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Toxicology Testing Market encompasses comprehensive drug testing solutions for identifying substance use issues related to mental health and various other medical conditions. This market is witnessing significant growth due to increasing healthcare priorities around early detection and prevention of substance-related disorders. Biotechnology companies and pharmaceuticals are major contributors to this market, leveraging technological advancements such as predictive toxicology, high-throughput screening, and combinatorial chemistry for preclinical evaluation of ADME properties and pharmacokinetic profiles. However, the use of animal testing in toxicology raises ethical concerns and public sentiment. Animal rights activists argue against the practice, leading to debates around alternative testing methods. The industry is responding with efforts to minimize animal usage and improve animal welfare. As the market evolves, it will continue to prioritize ethical testing practices while delivering accurate and reliable results for the benefit of public health.

Market Research Overview

The Toxicology Testing Market is experiencing significant growth due to the increasing demand for regulatory-approved therapies and the need for safety pharmacology in various industries. In-vitro toxicology tests, specifically those using HepatoSite in-vitro models and PhysioMimix, are becoming essential tools in the biopharmaceutical sector and the chemicals industry for assessing the ADME (absorption, distribution, metabolism, excretion) properties and pharmacokinetic profiles of drugs. The diagnostics segment is also witnessing a rise in demand for precision toxicology and personalized medicine, which require comprehensive drug testing using biological samples like hair, saliva, blood, and urine. Technological advancements, such as High-throughput screening, Toxicogenomics, In silico models, Ex vivo models, Molecular toxicology assays, Biochemical assays, and Cellular assays, are driving the market forward. Collaborative networks between regulatory authorities, technology providers, instrument & reagent suppliers, academic & research institutes, and biotechnology companies are also contributing to the market's growth. The healthcare industry segment, including addiction treatment, sports, forensic investigations, and workplace safety, is a significant consumer of toxicology testing services. Policy shifts and regulatory adjustments, digital platforms, telemedicine, and remote testing are also transforming the healthcare landscape, leading to the adoption of rapid testing and comprehensive drug testing. However, ethical concerns and public sentiment against animal testing are potential challenges for the market. Buying behavior is influenced by factors such as substance use issues, mental health, testing patterns, and healthcare priorities. The food industry and consumer care companies are also significant consumers of toxicology testing services in the Omics disciplines, including Metabolomics, Proteomics, and Genomics. In summary, the Toxicology Testing Market is witnessing a rise in demand due to the need for safety pharmacology, regulatory-approved therapies, and technological advancements. The market is diverse and includes various industries, applications, and technologies. However, ethical concerns and public sentiment against animal testing remain challenges that need to be addressed.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!